Valemetostat (DS-3201): Protocols & Troubleshooting in Lymph
2026-06-09
Valemetostat (DS-3201) empowers precise EZH2 mutant inhibition in relapsed/refractory lymphoma studies. This guide details stepwise protocols, advanced workflow optimizations, and actionable troubleshooting strategies that set APExBIO’s product apart in epigenetic cancer therapy research.
GRK Subtype Regulation of M1 Receptor Biased Signaling Mecha
2026-06-08
This study systematically dissects how distinct GRK subtypes modulate biased signaling of the M1 muscarinic acetylcholine receptor, with precise quantification of downstream G protein and β-arrestin engagement under various agonists and allosteric modulators. The findings clarify molecular determinants of pathway selectivity, informing targeted strategies for cognitive and Alzheimer's disease research.
Butyrate Induces Ferroptosis to Suppress Lung Cancer Stemnes
2026-06-08
This study reveals that butyrate attenuates the stemness of lung cancer cells by promoting lysosome Fe2+- and SLC7A11-mediated ferroptosis. The findings highlight a novel metabolic vulnerability in cancer stem cells and outline mechanistic details that broaden our understanding of ferroptosis as a therapeutic target.
Low-Affinity N-Type Ca Channel Block by v-Agatoxin-IVA: New
2026-06-07
Sidach and Mintz's study rigorously re-examines the pharmacological selectivity of the spider toxin v-Agatoxin-IVA, revealing that at higher concentrations it incompletely blocks neuronal N-type calcium channels with low affinity. These findings challenge the conventional use of v-Aga-IVA as a strictly P-type channel marker and have significant implications for experimental design in neurophysiology.
Tioconazole: Mechanism, Benchmarks, and Research Utility
2026-06-06
Tioconazole is a potent antifungal medication that inhibits fungal ergosterol biosynthesis by targeting cytochrome P450 enzymes. Its high purity and versatile solubility make it valuable for antifungal drug development and infection modeling. This article clarifies Tioconazole’s mechanism, evidence base, and common pitfalls for robust research applications.
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S
2026-06-05
Shapira-Netanelov et al. present a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal subpopulations, capturing complex microenvironmental features absent from conventional systems. This platform enhances physiological relevance for drug screening, revealing how stroma modulates both gene expression and therapeutic response, and supports the development of more predictive preclinical oncology assays.
Magneto-Piezoelectric Scaffolds Drive Macrophage-Mediated Bo
2026-06-05
This study introduces a multifunctional scaffold enhanced with magneto-piezoelectric nanoparticles that disrupts bacterial biofilms and activates oxidative phosphorylation in Icam1+ macrophages for infectious bone defect regeneration. By targeting JAK2-STAT3 signaling, the approach offers a dual solution to infection control and bone healing, marking a significant advance in immunoregenerative biomaterials.
Gly-Gly-Phe-Gly: Elevating Drug Conjugation Workflows
2026-06-04
The GGFG peptide delivers unmatched flexibility for drug conjugation and antibody-drug conjugate engineering, streamlining workflows in bioconjugation chemistry. Explore how APExBIO’s high-purity GGFG enables precise, reproducible results and discover advanced troubleshooting strategies to optimize your experimental designs.
Palmitic acid (Hexadecanoic Acid): Technical Guidance for Re
2026-06-04
Palmitic acid (SKU N2456) provides researchers with a high-purity, well-characterized saturated long-chain fatty acid for studies in lipid metabolism, protein palmitoylation, and metabolic disorder research. This product is not suitable for workflows requiring aqueous solubility or for experiments needing long-term solution stability.
YM-155 Hydrochloride: Precision Survivin Inhibition in Trans
2026-06-03
Explore how YM-155 hydrochloride enables robust, reproducible survivin inhibitor research. Discover advanced assay guidance, nuanced data interpretation, and translational model insights that distinguish this cornerstone article from existing content.
Mycophenolic Acid: Dehydrogenase Inhibitor in Immune Modulat
2026-06-03
Discover how Mycophenolic acid enables precision immune metabolism research through robust, standardized whole-blood assays and metabolic intervention workflows. This article translates cutting-edge protocol advances and troubleshooting insights into actionable steps for researchers seeking high-fidelity immunometabolic data.
Cell Counting Kit-8 (CCK-8): Precision Cell Proliferation As
2026-06-02
The Cell Counting Kit-8 (CCK-8) empowers researchers with sensitive, high-throughput detection of cell viability and cytotoxicity, streamlining cancer and biomedical workflows. Recent studies reveal how CCK-8 enables robust quantification of proliferation dynamics, supporting cutting-edge epigenetic and drug response research.
Targeting Cell Surface NPM1 in AML: Innovation and Profiling
2026-06-02
This study identifies cell surface nucleophosmin (csNPM1) as a novel, tumor-selective antigen in acute myeloid leukemia (AML), demonstrating its utility as a target for immunotherapy. The work advances the field by characterizing csNPM1 expression and developing a monoclonal antibody with robust anti-leukemic activity and minimal toxicity.
lncRNA HITT Modulates ATM and Sensitizes Cancers to DNA Dama
2026-06-01
This study identifies the long noncoding RNA HITT as a direct inhibitor of ATM kinase activation, impairing homologous recombination repair and increasing cancer cell sensitivity to genotoxic agents. These findings provide new mechanistic insight into the regulation of DNA damage responses, offering translational relevance for optimizing chemotherapeutic strategies.
DiscoveryProbe FDA-approved Drug Library: Workflows & Innova
2026-06-01
The DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) empowers translational scientists with 2,320 clinically validated compounds, streamlining drug repositioning, pharmacological target identification, and high-throughput screening. This article delivers practical experimental workflows, troubleshooting strategies, and highlights from recent antiviral screening breakthroughs.
462 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page